Beta-blocker therapy in patients with left ventricular systolic dysfunction and chronic obstructive lung disease in an ambulatory care setting

Autor: Billups SJ, Delate T, Schimmer JJ

Publikováno v: Pharmacy Practice, Vol 7, Iss 4, Pp 205-212 (2009)

Objective: To evaluate beta blocker persistence six months after beta-blocker initiation or dose titration in heart failure (HF) patients with COPD compared to those without COPD. Secondary objectives included comparison of beta-blocker dose achieved

Externí odkaz: https://doaj.org/article/14f9591bb9984300a551b196e58a6c8d

Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitor Use.

Autor: Kim OM; Pharmacy Department, Kaiser Permanente Northwest, Portland, OR., Givens TK; Pharmacy Department, Kaiser Permanente Georgia, Atlanta, GA.; Pharmacy Department, VillageMD, Atlanta, GA; and., Tang EG; Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO.; Pharmacy Department, Yale New Haven Hospital, New Haven, CT., Schimmer JJ; Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO., Ramsey T; Pharmacy Department, Kaiser Permanente Northwest, Portland, OR., Boyd K; Pharmacy Department, Kaiser Permanente Georgia, Atlanta, GA., Delate T; Pharmacy Outcomes Research Group, Kaiser Permanente National Pharmacy Services, Aurora, CO.

Publikováno v: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2023 May 01; Vol. 81 (5), pp. 339-347. Date of Electronic Publication: 2023 May 01.